SCHEMBL10429332

SCHEMBL10429332

N#Cc1cc(-c2nsc3c(=O)[nH]nnc23)ccc1OCCCO

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
XDH P47989 7/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10429327 0.96 XDH (0.47) XDH
SCHEMBL10429306 0.86 XDH (0.42) XDH
SCHEMBL10429330 0.85 XDH (0.38) XDH
SCHEMBL7165222 0.84 F11 (0.40) XDH
SCHEMBL10429356 0.76 ALDH1A1 (0.32) XDH
SCHEMBL10429323 0.71 MAOB (0.40) XDH
SCHEMBL7165524 0.70 GRM5 (0.41)
SCHEMBL7162696 0.70 PDE4A (0.38)
SCHEMBL10429340 0.68 NOTUM (0.39)
SCHEMBL7162474 0.68 CTSS (0.37) XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4920119-A XANTHINE OXIDASE INHIBITORS; CONTROL OR PREVENTION OF GOUT OR ISCHEMIA HOFFMANN-LA ROCHE INC. (US) 1990-04-24 US disclosed
EP-0274654-A2 1,2,3-Triazin-4(3H)-one derivatives, process for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE AG (CH) 1988-07-20 EP disclosed